For Appointments


Active clinical trials for Rheumatology:

A Randomized, Head-to-Head, Single-Blinded Study to Assess Changes in the Immune Profile in Response to Treatment with Subcutaneous Abatacept in Combination with Methotrexate versus Subcutaneous Adalimumab in Combination with Methotrexate in Adults with Early Rheumatoid Arthritis who are Naive to Biologic Disease-Modifying Antirheumatic Drugs The immune system of patients with Rheumatoid Arthritis (RA) is different from that of people who do not have RA. The purpose of this study is to examine your immune cells and proteins before you start to take study medication and after you start treatment with one of two approved therapies for RA, abatacept versus adalimumab, both given in combination with methotrexate. This study will also check whether characteristics of your immune system assessed before you receive any study drug affect your response to the study drug received.
More information
STOP Scleroderma The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.
More information
Wound Etiology and Healing Study (WE-HEAL) The purpose of the WE-HEAL Study is to help researchers use human tissue samples and health records to study the reasons why some patients heal quickly and some have problems healing wounds. All patients seen with an open wound and Hidradenitis suppurativa are asked to participate. Information from this research may help to understand how to prevent and treat certain diseases.
More information